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Thefirstreporteduseofelectricityforitsnumbing
effect was in AD 46 by a Roman. '2 Since then
electro analgesia has beenused in the USA in the
1850s and peripheral nerve stimulation has been
used sporadically since. In 1965 Shealy and
colleagues demonstrated that spinal cord
stimulation (SCS) in cats blocked behavioural
responses to acute pain,3'4 and the same group
subsequently implanted a spinal cord stimulator
in a patient in 1967, reducing his chest wall
cancer pain.5 With these results SCS has been
used with mixed results in a variety of pain
conditions. In 1984, Sandric and colleagues
reportedthatpatientsundergoing SCSforvarious
conditions who also had ischaemic heart disease
showed improvements intheirECG, andtwohad
no further angina.6 Murphy and Giles (1987)
were the first to report the technique being used
specifically for angina.
This isthefirstreporteduseofaMedtronic spinal
cord stimulator for angina in Northern Ireland.
CASE REPORT A 52-year-old man with
intractable anginawasreferred. Hehadtwo acute
myocardialinfarctions andcoronaryarterybypass
grafting (CABG) in March 1989. There was a
gradual return of angina since 1993. There was
further angiographically demonstrated coronary
artery disease progression and so CABG was
performedagainin 1995butitwasnotpossibleto
bypass all the occlusions. Subsequently he had
frequent episodes of angina, requiring hospital
admission for analgesia and nitrate infusions for
atotal of78 days overtheprevious calendaryear.
METHOD
The patient was given pre-medication of
clonazepam lmg. orally 2 hours prior to the
procedure. Continuous ECG, bloodpressure and
Sp02 were monitoredthroughout andhe received
oxygen by face mask during the insertion. The
epidural space was identified with fluoroscopic
assistance using loss of resistance to air with a
wingless 16 guage epidural needle with a 7.5mm
terminal orifice (to allow advancement and
withdrawal of the electrode without danger of
electrode damage). The needle tip was placed in
the mid-line ofthe epidural space. The electrode
was advanced under x-ray control so that its tip
lay just to the left of the midline at C7 and a
stimulation trial carried out (the wire has 4
electrodes (0,1,2,3)eachofwhichcanbepositive
or negative, on or off, allowing variable
stimulation over afairly wide area). The aim was
to achieve stimulation (paraesthesia) over the
area where angina was felt; this was achieved.
When satisfactory stimulation was achieved a
2cm incision through skin was made caudal and
cephalad to the epidural needle, a subcutaneous
pocket created, needle withdrawn ensuring no
movement ofthe electrode wire and the wire end
attached to a subcutaneously tunnelled cable
which emerged 10cm from the midline and
attachedagaintotheexternalhandheldstimulator.
After 4 days of trial stimulation the patient
reported no episodes of angina and an increased
exercise tolerance, so a permanent receiver was
implantedsubcutaneously. Thepatientwasfurther
instructed in how to use the stimulator.
RESULTS
Over a 36-week follow-up period the patient has
had angina on a much reduced frequency and on
one occasion it was found that the electrode wire
had migrated cephalad, and after suitable
withdrawal satisfactory stimulation had been re-
achieved his angina was reduced again to its new
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much reduced state. His exercise tolerance has
also increased. His frequency of hospital
admission has also been reduced to 3 admissions
totalling 9 days over an 8 month period.
COMMENT
ThemechanismofpainreliefbySCSisunknown.8
One concern is that angina, (a potential warning
signal) of impending myocardial ischaemia)
would be masked. In a series of 50 patients with
intractableanginainwhomspinalcordstimulation
wasperformedfor 1-57 months,tensubsequently
died due to acute myocardial infarction.9 In nine
spinalcordstimulationdidnotconcealprecordial
pain and in one no information about precordial
paincouldbeobtained.9Inotherseriescontinuous
ECGmonitoringhasdemonstratedlessischaemic
changes during exercise in those with SCS and
intractable angina when compared to a non
stimulated group, 10 11, 12 and furthermore, less
ischaemia provoked by increased pacing
frequencyinthosewithconcomitantpacemakers
in situ whencomparedto acontrol group.13 When
monitored electrocardiographically after
adenosine infusion, decreases in left ventricular
ejection fraction were less marked in the SCS
group when compared to those unstimulated.14It
doestherefore seemthattheeffectofSCS ismore
than a simple masking effect and may actually
improve myocardial oxygen supply thereby
reducing angina.
SCS is expensive. The price of an electrode and
receiver is around £5,300. However, it reduced
suffering and hospital admissions in this case.
Hopefully this case has highlighted potentially
useful analgesic effects of SCS in a patient with
intractable angina.
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